Effect of chronic hyperoxic exposure on duroquinone reduction in adult rat lungs

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 5 33-5, 2005, Pages

  Audi, Said H ^a,c,d   Bongard, Robert D ^c   Krenz, Gary S ^b   Rickaby, David A ^c,d   Haworth, Steven T ^c   Eisenhauer, Jessica ^c   Roerig, David L ^c,d   Merker, Marilyn P ^c,d  

^a Medical College of Wisconsin and Marquette University   (United States)

^b MARQUETTE UNIVERSITY   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Mathematical modeling; Mitochondrial electron transport; NAD(P)H:quinone oxidoreductase; Oxidative stress; Pulmonary endothelium

Indexed keywords

DUROQUINOL; DUROQUINONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HYPEROXIA; KINETICS; LUNG ALVEOLUS EPITHELIUM; MATHEMATICAL MODEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; REDUCTION; RESPIRATORY CHAIN;

ANIMALS; BENZOQUINONES; CHRONIC DISEASE; HYPEROXIA; KINETICS; LUNG; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATION-REDUCTION; PERFUSION; PULMONARY CIRCULATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 27144481919     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00064.2005     Document Type: Article

References (34)

1. Audi SH, Bongard RD, Dawson CA, Siegel D, Roerig DL, and Merker MP. Duroquinone reduction during passage through the pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 285: L1116-L1131, 2003.
2. Audi SH, Bongard RD, Okamoto Y, Merker MP, Roerig DL, and Dawson CA. Pulmonary reduction of an intravascular redox polymer. Am J Physiol Lung Cell Mol Physiol 280: L1290-L1299, 2001.
3. Audi SH, Dawson CA, Ahlf SB, and Roerig DL. Lung tissue mitochondrial benzodiazepine receptors increase in a model of pulmonary inflammation. Lung 180: 241-250, 2002.
4. Audi SH, Dawson CA, Ahlf SB, and Roerig DL. Oxygen dependency of monoamine oxidase activity in the intact lung. Am J Physiol Lung Cell Mol Physiol 281: L969-L981, 2001.
5. Audi SH, Linehan JH, Krenz GS, and Dawson CA. Accounting for the heterogeneity of capillary transit times in modeling multiple indicator dilution data. Ann Biomed Eng 26: 914-930, 1998.
6. Audi SH, Olson LE, Bongard RD, Roerig DL, Schulte ML, and Dawson CA. Toluidine blue O and methylene blue as endothelial redox probes in the intact lung. Am J Physiol Heart Circ Physiol 278: H137-H150, 2000.
7. Bass L and Robinson PJ. Effects of capillary heterogeneity on rates of steady uptake of substances by the intact liver. Microvasc Res 22: 43-57, 1981.
8. Beyer RE, Segura-Aguilar J, Di Bernardo S, Cavazzoni M, Fato R, Fiorentini D, Galli MC, Setti M, Landi L, and Lenaz G. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems. Proc Natl Acad Sci USA 93: 2528-2532, 1996.
9. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol 49: 127-140, 1995.
10. Cadenas E, Boveris A, Ragan CI, and Stoppani AO. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys 180: 248-257, 1977.
11. Chang LY, Kang BH, Slot JW, Vincent R, and Crapo JD. Immunocytochemical localization of the sites of superoxide dismutase induction by hyperoxia in rat lungs. Lab Invest 73: 29-39, 1995.
12. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, and Kleeberger SR. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 26: 175-182, 2002.
13. Coursin DB, Cihla HP, Will JA, and McCreary JL. Adaptation to chronic hyperoxia. Biochemical effects and the response to subsequent lethal hyperoxia. Am Rev Respir Dis 135: 1002-1006, 1987.
14. Crapo JD, Barry BE, Foscue HA, and Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am Rev Respir Dis 122: 123-143, 1980.
15. Crapo JD and Tierney DF. Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol 226: 1401-1407, 1974.
16. Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, and Harman D. Oxygen radicals and human disease. Ann Intern Med 107: 526-545, 1987.
17. Dinkova-Kostova AT and Talalay P. Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic Biol Med 29: 231-240, 2000.
18. Forman HJ and Fisher AB. Antioxidant enzymes of rat granular pneumocytes. Constitutive levels and effect of hyperoxia. Lab Invest 45: 1-6, 1981.
19. Halliwell B. Free Radicals in Biology and Medicine. New York: Oxford, 1999.
20. Ho YS. Transgenic and knockout models for studying the role of lung antioxidant enzymes in defense against hyperoxia. Am J Respir Crit Care Med 166: S51-S56, 2002.
21. Ho YS, Dey MS, and Crapo JD. Antioxidant enzyme expression in rat lungs during hyperoxia. Am J Physiol Lung Cell Mol Physiol 270: L810-L818, 1996.
22. Lind C, Cadenas E, Hochstein P, and Ernster L. DTdiaphorase: purification, properties, and function. Methods Enzymol 186: 287-301, 1990.
23. Ma Q, Cui K, Wang RW, Lu AY, and Yang CS. Site-directed mutagenesis of rat liver NAD(P)H: quinone oxidoreductase: roles of lysine 76 and cysteine 179. Arch Biochem Biophys 294: 434-439, 1992.
24. Merker MP, Bongard RD, Krenz GS, Zhao H, Fernandes VS, Kalyanaraman B, Hogg N, and Audi SH. Impact of pulmonary arterial endothelial cells on duroquinone redox status. Free Radic Biol Med 37: 86-103, 2004.
25. O'Donnell VB, Smith GC, and Jones OT. Involvement of phenyl radicals in iodonium inhibition of flavoenzymes. Mol Pharmacol 46: 778-785, 1994.
26. Otterbein LE and Choi AM. The saga of leucine zippers continues: in response to oxidative stress. Am J Respir Cell Mol Biol 26: 161-163, 2002.
27. Pitt BR, Lister G, Davies P, and Reid LM. Effects of changes in pulmonary perfusion and surface area on endothelial ACE activity. Ann Biomed Eng 15: 229-238, 1987.
28. Ross D, Siegel D, Beall H, Prakash AS, Mulcahy RT, and Gibson NW. DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev 12: 83-101, 1993.
29. Siegel D, Franklin WA, and Ross D. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors. Clin Cancer Res 4: 2065-2070, 1998.
30. Siegel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, and Ross D. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 65: 1238-1247, 2004.
31. Siegel D and Ross D. Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 29: 246-253, 2000.
32. Wang Y, Feinstein SI, Manevich Y, Ho YS, and Fisher AB. Lung injury and mortality with hyperoxia are increased in peroxiredoxin 6 gene-targeted mice. Free Radic Biol Med 37: 1736-1743, 2004.
33. Whitney PL and Frank L. Does lung NAD(P)H:quinone reductase (DT-diaphorase) play an antioxidant enzyme role in protection from hyperoxia? Biochim Biophys Acta 1156: 275-282, 1993.
34. Wosilait WD, Ryan MP, and Byington KH. Uptake of anticoagulants by isolated rat hepatocytes. Drug Metab Dispos 9: 80-84, 1981.